Titan Pharmaceuticals Inc (TTNP): So that would explain the 2-3 point spre...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: TRUISM post# 1346

Thursday, 04/25/2013 11:07:57 AM

Thursday, April 25, 2013 11:07:57 AM

So that would explain the 2-3 point spread were seeing then??

Keep Last Read

Replies (1) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 09:10:20 PM
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/21/2024 12:32:38 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/19/2024 08:23:26 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 08:22:56 PM
Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. • GlobeNewswire Inc. • 08/19/2024 08:11:12 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2024 01:29:55 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2024 01:29:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:33:11 PM
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria • GlobeNewswire Inc. • 01/25/2024 09:29:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:59:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 10:13:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:20 PM
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio • GlobeNewswire Inc. • 12/28/2023 09:15:00 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:47:46 PM

InvestorsHub NewsWire

Only $200 per official company press release!